Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial

View ORCID ProfileÁlvaro Hernáez, Olga Castañer, Anna Tresserra-Rimbau, Xavier Pintó, Montserrat Fitó, Rosa Casas, Miguel Ángel Martínez-González, Dolores Corella, Jordi Salas-Salvadó, José Lapetra, Enrique Gómez-Gracia, Fernando Arós, Miquel Fiol, Lluis Serra-Majem, Emilio Ros, Ramón Estruch
doi: https://doi.org/10.1101/19001909
Álvaro Hernáez
1Cardiovascular Risk, Nutrition and Aging Research Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
3Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Álvaro Hernáez
  • For correspondence: alvaro.hernaez1@gmail.com
Olga Castañer
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
3Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Tresserra-Rimbau
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
4Human Nutrition Unit, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Reus, Spain
5Hospital Universitari San Joan de Reus, Reus, Spain
6Institut d’Investigació Pere Virgili (IISPV), Reus, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Pintó
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
7Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, L’Hospitalet de Llobregat, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Montserrat Fitó
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
3Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Casas
1Cardiovascular Risk, Nutrition and Aging Research Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Ángel Martínez-González
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
8Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain
9Department of Nutrition, Harvard TH Chan School of Public Health, Boston, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dolores Corella
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
10Department of Preventive Medicine, Universidad de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Salas-Salvadó
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
4Human Nutrition Unit, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, Reus, Spain
5Hospital Universitari San Joan de Reus, Reus, Spain
6Institut d’Investigació Pere Virgili (IISPV), Reus, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Lapetra
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
11Department of Family Medicine. Research Unit. Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Gómez-Gracia
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
12Department of Preventive Medicine and Public Health, Universidad de Málaga, Málaga, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Arós
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
13Department of Cardiology, Hospital Universitario de Álava, Vitoria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miquel Fiol
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
14Health Research Institute of the Balearic Islands (IdISBa). Hospital Son Espases. Palma de Mallorca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lluis Serra-Majem
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
15Department of Clinical Sciences, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilio Ros
1Cardiovascular Risk, Nutrition and Aging Research Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
16Lipid Clinic, Endocrinology and Nutrition Service, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramón Estruch
1Cardiovascular Risk, Nutrition and Aging Research Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
2CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
17Internal Medicine Service, Hospital Clínic, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Scope To assess whether following a Mediterranean diet (MedDiet) improves atherothrombosis biomarkers in high cardiovascular risk individuals.

Methods and results In 358 random volunteers from the PREDIMED trial (Prevención con Dieta Mediterránea), we assessed the 1-year effects on atherothrombosis markers of an intervention with MedDiet, enriched with virgin olive oil (MedDiet-VOO; N=120) or nuts (MedDiet-Nuts; N=119) versus a low-fat control diet (N=119). In a secondary, observational approach, we studied whether volunteers with large increments in MedDiet adherence (>2 score points) were associated with 1-year improvements in biomarkers (relative to those worsening their adherence). The MedDiet-VOO intervention increased platelet activating factor-acetylhydrolase activity in high-density lipoproteins (HDLs) by 7.5% [95% confidence interval: 0.17; 14.8] and decreased HDL-bound α1-antitrypsin levels by 6.1% [−11.8; −0.29]. The MedDiet-Nuts one reduced non-esterified fatty acid concentrations by 9.3% [−18.1; −0.53]. Only the low-fat diet was associated with increases in platelet factor-4 and prothrombin factor1+2 levels versus baseline (P=0.012 and P=0.003, respectively, according to Wilcoxon signed-rank tests). Finally, large MedDiet increments were associated with less fibrinogen (−9.5% [−18.3; −0.60]) and non-esterified fatty acid concentrations (−16.7% [−31.7; −1.74]).

Conclusion Following a MedDiet improves atherothrombosis biomarkers in high cardiovascular risk individuals.

Competing Interest Statement

X.P. reports to be a board member, lecture fees, and grants from Ferrer International; to be a board member and grants from the Residual Risk Reduction Initiative Foundation; personal fees from Abbott Laboratories; lecture fees and grants from Merck and Roche; lecture fees from Danone, Esteve, Menarini, Mylan, LACER, and Rubio Laboratories; and grants from Sanofi, Kowa, Unilever, Boehringer Ingelheim, and Karo Bio. J.S.-S. reports to be a board member and personal fees from Instituto Danone Spain; to be a board member and grants from the International Nut and Dried Fruit Foundation; personal fees from Aguas Font Vella Lanjarón, and Danone S.A; and grants from Eroski Distributors. F.A. reports personal fees from Menarini and AstraZeneca. L.S.-M. reports to be a board member of the Mediterranean Diet Foundation and the Beer and Health Foundation. E.R. reports personal fees, grants, and nonfinancial support from the California Walnut Commission, Merck Sharp & Dohme, Alexion, and Ferrer International; personal fees and nonfinancial support from Aegerion, Amarin, and Danone; personal fees and grants from Sanofi; and grants from Amgen and Pfizer. R.E. reports to be a board member of the Research Foundation on Wine and Nutrition, the Beer and Health Foundation, and the European Foundation for Alcohol Research; personal fees from KAO Corporation; lecture fees from Instituto Cerventes, Fundacion Dieta Mediterranea, Cerveceros de España, Lilly Laboratories, AstraZeneca, and Sanofi; and grants from Novartis, Amgen, Bicentury, and Grand Fountaine. The rest of the authors have nothing to disclose.

Clinical Trial

ISRCTN35739639

Funding Statement

This work was supported by grants of Instituto de Salud Carlos III [OBN17PI02, PIE14/00045_INFLAMES, CB06/03/0019, CB06/03/0028, and CD17/00122 (A.H.)], and Agència de Gestió d’Ajuts Universitaris i de Recerca (2017 SGR 222). CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN) is an initiative of the Instituto de Salud Carlos III, Madrid, Spain.

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Data Availability

Considering that we do not have the explicit written consent of the study volunteers to yield their deidentified data at the conclusion of the study, individual participant data cannot be shared. The study protocol is available in the main publication of the study1 and in the study website (http://www.predimed.es/uploads/8/0/5/1/8051451/_1estr_protocol_olf.pdf), and a summary of the dietary intervention is also available in Supplemental Methods.

  • Abbreviations

    MedDiet
    Traditional Mediterranean Diet
    MedDiet-Nuts
    Traditional Mediterranean Diet enriched in nuts
    MedDiet-VOO
    Traditional Mediterranean Diet enriched in virgin olive oil
    NEFA
    non-esterified fatty acids
    PAF-AH
    platelet activating factor-acetylhydrolase
    PAI-1
    plasminogen activator inhibitor-1
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 15, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial
    Álvaro Hernáez, Olga Castañer, Anna Tresserra-Rimbau, Xavier Pintó, Montserrat Fitó, Rosa Casas, Miguel Ángel Martínez-González, Dolores Corella, Jordi Salas-Salvadó, José Lapetra, Enrique Gómez-Gracia, Fernando Arós, Miquel Fiol, Lluis Serra-Majem, Emilio Ros, Ramón Estruch
    medRxiv 19001909; doi: https://doi.org/10.1101/19001909
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Mediterranean Diet and atherothrombosis biomarkers: a randomized controlled trial
    Álvaro Hernáez, Olga Castañer, Anna Tresserra-Rimbau, Xavier Pintó, Montserrat Fitó, Rosa Casas, Miguel Ángel Martínez-González, Dolores Corella, Jordi Salas-Salvadó, José Lapetra, Enrique Gómez-Gracia, Fernando Arós, Miquel Fiol, Lluis Serra-Majem, Emilio Ros, Ramón Estruch
    medRxiv 19001909; doi: https://doi.org/10.1101/19001909

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Nutrition
    Subject Areas
    All Articles
    • Addiction Medicine (239)
    • Allergy and Immunology (521)
    • Anesthesia (124)
    • Cardiovascular Medicine (1418)
    • Dentistry and Oral Medicine (217)
    • Dermatology (158)
    • Emergency Medicine (291)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
    • Epidemiology (10288)
    • Forensic Medicine (6)
    • Gastroenterology (527)
    • Genetic and Genomic Medicine (2625)
    • Geriatric Medicine (254)
    • Health Economics (496)
    • Health Informatics (1729)
    • Health Policy (789)
    • Health Systems and Quality Improvement (671)
    • Hematology (266)
    • HIV/AIDS (564)
    • Infectious Diseases (except HIV/AIDS) (12083)
    • Intensive Care and Critical Care Medicine (648)
    • Medical Education (273)
    • Medical Ethics (83)
    • Nephrology (288)
    • Neurology (2456)
    • Nursing (144)
    • Nutrition (377)
    • Obstetrics and Gynecology (491)
    • Occupational and Environmental Health (566)
    • Oncology (1319)
    • Ophthalmology (400)
    • Orthopedics (146)
    • Otolaryngology (235)
    • Pain Medicine (168)
    • Palliative Medicine (51)
    • Pathology (342)
    • Pediatrics (778)
    • Pharmacology and Therapeutics (329)
    • Primary Care Research (296)
    • Psychiatry and Clinical Psychology (2394)
    • Public and Global Health (4999)
    • Radiology and Imaging (893)
    • Rehabilitation Medicine and Physical Therapy (525)
    • Respiratory Medicine (681)
    • Rheumatology (309)
    • Sexual and Reproductive Health (255)
    • Sports Medicine (244)
    • Surgery (297)
    • Toxicology (45)
    • Transplantation (140)
    • Urology (108)